Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Putting the Best Minds on the Hardest Matters

Mental wellbeing is a defining challenge in health communications. High workloads, constant connectivity and leadership gaps are driving widespread burnout, with serious impacts on creativity, productivity and retention. Minds on...

Fox&Cat

- PMLiVE

Learn the golden standard for omnichannel strategies!

Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar to learn how to eliminate silos and turn fragmented data into actionable insights. Register...

Impetus Digital

- PMLiVE

Ipsen to acquire ImCheck Therapeutics in a deal worth up to €1bn

The acquisition includes a clinical stage acute myeloid leukaemia treatment currently in phase 1/2 trials

- PMLiVE

Excellence in Healthcare Partnerships Awards Networking Event

From plan to partnership: navigating the enablers and challenges of collaborative working

5 mistakes to avoid when creating clinical content mark

5 mistakes to avoid when creating clinical content marketing

In this article, we’ll share 5 common mistakes that we’ve uncovered in our years of experience creating clinical content. Helping you avoid these mistakes is part of the service we...

Springer Nature

- PMLiVE

Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions

New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...

BOLDSCIENCE

- PMLiVE

World Orphan Drug Congress 2025 in Amsterdam

Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.

Medscape Education

- PMLiVE

ViiV Healthcare receives NICE recommendation for HIV prevention therapy

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

- PMLiVE

Aqilion announces positive results from eosinophilic esophagitis treatment study

Phase 2 trials for EoE are now expected to be initiated in Europe, Canada and the US

- PMLiVE

Sanofi reports improved patient outcomes from high-dose influenza vaccine

Study data shows a reduced risk of hospitalisation in older adults compared with standard-dose vaccines

- PMLiVE

Mainz Biomed reports on blood-based screening test for pancreatic cancer

The study demonstrated strong clinical accuracy in differentiating pancreatic cancer patients from control subjects

- PMLiVE

Mission Therapeutics advances Parkinson’s disease candidate

The company also received a grant from the Michael J. Fox Foundation and Parkinson’s UK

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links